SubsidieMeestersArticular Cartilage Treatment with Injectable hydrogel is Valuable and long-term Effective
Hy2Care develops a regenerative injectable hydrogel for cartilage repair, promoting natural healing and long-lasting joint health while preventing osteoarthritis.
Projectdetails
Introduction
Hy2Care brings a regenerative Injectable Hydrogel, of joint- and cartilage-mimicking composition, that is used to treat damaged cartilage. The cartilage defects are easily filled with a syringe during a standard one-time arthroscopy.
Mechanism of Action
The hydrogel fills the defect, prevents ingrowth of scar tissue, and allows the body to heal itself by creating true Hyaline cartilage, ensuring optimal regenerated tissue.
Benefits of the Hydrogel
- The high-quality regeneration provides the basis for a long-lasting repair, postponing or even preventing the onset of osteoarthritis.
- The gel binds covalently to the surrounding cartilage, ensuring integration of the new tissue.
- Revalidation is fast as the cartilage regrowth follows the degradation of the gel.
Economic Impact
The lasting repair not only prevents additional secondary treatments but also pain, disability, and escalating follow-on costs.
Recognition
In submission of the last cut-off of the EIC in October 2020, Hy2Care scored a 14.0 and received the seal of excellence.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.500.000 |
| Totale projectbegroting | € 3.692.412 |
Tijdlijn
| Startdatum | 1-10-2022 |
| Einddatum | 30-9-2024 |
| Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- HY2CARE BVpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Rebuilding Joint Surface to Prevent Pain and ImmobilityAskel's COPLA® implant promotes cartilage regeneration and quick rehabilitation to prevent osteoarthritis, aiming to establish a gold standard for pain-free joint movement and improved quality of life. | EIC Accelerator | € 2.499.000 | 2022 | Details |
A breakthrough active immunotherapy for the treatment of osteoarthritisPeptinov aims to halt osteoarthritis progression through a cost-effective immunotherapy that neutralizes IL-6, with promising Phase I results leading to a Phase II trial for out-licensing readiness. | EIC Accelerator | € 2.499.999 | 2024 | Details |
A novel non-invasive therapy based on injectable viscous gel for restoring the natural biomechanics of the spine and relieving patients from painNC Biomatrix's VitaDisc is a revolutionary non-invasive injectable biomatrix that restores disc function and height, addressing disc degeneration and offering a scalable solution for orthopedic treatments. | EIC Accelerator | € 2.499.999 | 2023 | Details |
The Holy Grail in Bone regenerationGreenBone aims to revolutionize bone grafts with a synthetic Rattan wood-based implant that mimics natural bone, enhancing regeneration and targeting the spinal market by 2025. | EIC Accelerator | € 2.458.128 | 2022 | Details |
Rebuilding Joint Surface to Prevent Pain and Immobility
Askel's COPLA® implant promotes cartilage regeneration and quick rehabilitation to prevent osteoarthritis, aiming to establish a gold standard for pain-free joint movement and improved quality of life.
A breakthrough active immunotherapy for the treatment of osteoarthritis
Peptinov aims to halt osteoarthritis progression through a cost-effective immunotherapy that neutralizes IL-6, with promising Phase I results leading to a Phase II trial for out-licensing readiness.
A novel non-invasive therapy based on injectable viscous gel for restoring the natural biomechanics of the spine and relieving patients from pain
NC Biomatrix's VitaDisc is a revolutionary non-invasive injectable biomatrix that restores disc function and height, addressing disc degeneration and offering a scalable solution for orthopedic treatments.
The Holy Grail in Bone regeneration
GreenBone aims to revolutionize bone grafts with a synthetic Rattan wood-based implant that mimics natural bone, enhancing regeneration and targeting the spinal market by 2025.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Development of a Complete Triple Action Injectable Treatment for OsteoarthritisRelevium Ltd aims to validate and commercialize Hydrobloc, a unique therapy that regenerates cartilage, alleviates pain, and improves joint function in osteoarthritis patients. | EIC Transition | € 2.398.115 | 2022 | Details |
SyCap MechanoAvalanche Medical ontwikkelt een duurzaam kunststof implantaat voor kraakbeendefecten in de knie, gericht op middelbare leeftijd patiënten. | Mkb-innovati... | € 20.000 | 2022 | Details |
Restoring the structural collagen network in the regeneration of cartilageRe-COLL aims to develop durable implants for damaged joints by engineering anisotropic collagen networks through biofabrication and in vitro models, enhancing tissue regeneration and stability. | ERC Advanced... | € 2.500.000 | 2024 | Details |
Rejuvenation of the Intervertebral Disc Using Self-Healing Biomimetic Extracellular Matrix Biomaterial Tissue AdhesivesThis project aims to develop a self-healing biomimetic hydrogel for treating degenerated intervertebral discs, restoring tissue properties and improving patient outcomes in minimally invasive spine treatments. | ERC Proof of... | € 150.000 | 2024 | Details |
The hydrocup: a hollow electrospun scaffold for in vivo cell-laden hydrogel deliveryDeveloping a hollow electrospun scaffold for localized delivery of viable stem cells to enhance cytokine secretion and support cardiac regeneration, with plans for commercialization. | ERC Proof of... | € 150.000 | 2022 | Details |
Development of a Complete Triple Action Injectable Treatment for Osteoarthritis
Relevium Ltd aims to validate and commercialize Hydrobloc, a unique therapy that regenerates cartilage, alleviates pain, and improves joint function in osteoarthritis patients.
SyCap Mechano
Avalanche Medical ontwikkelt een duurzaam kunststof implantaat voor kraakbeendefecten in de knie, gericht op middelbare leeftijd patiënten.
Restoring the structural collagen network in the regeneration of cartilage
Re-COLL aims to develop durable implants for damaged joints by engineering anisotropic collagen networks through biofabrication and in vitro models, enhancing tissue regeneration and stability.
Rejuvenation of the Intervertebral Disc Using Self-Healing Biomimetic Extracellular Matrix Biomaterial Tissue Adhesives
This project aims to develop a self-healing biomimetic hydrogel for treating degenerated intervertebral discs, restoring tissue properties and improving patient outcomes in minimally invasive spine treatments.
The hydrocup: a hollow electrospun scaffold for in vivo cell-laden hydrogel delivery
Developing a hollow electrospun scaffold for localized delivery of viable stem cells to enhance cytokine secretion and support cardiac regeneration, with plans for commercialization.